HTA Council Recommendation (as of 18 June 2025) The HTA Council positively recommends the government financing of In Vitro Quantitative HIV Nucleic Acid Test (HIV NAT-1) for screening and diagnosis of HIV type 1 infection in HIV-exposed infants and children. The HTA Council strongly recommends that implementation of HIV health technologies should follow the WHO continue reading : In Vitro Quantitative HIV Nucleic Acid Test (HIV NAT-1) for screening and diagnosis of HIV type 1 infection in HIV-exposed infants and children
Tetanus, Diphtheria, and Acellular Pertussis (Tdap) Vaccine as an active booster immunization against tetanus, diphtheria and pertussis
HTA Council Final Recommendation (as of 26 May 2025) The HTA Council positively recommends the government financing of Tetanus, Diphtheria, and Acellular Pertussis (Tdap) Vaccine for the following populations: Relevant Information Evidence and Relevant Documents Assessment History Back to Assessments Page